Vestar MR
Tablet (Modified Release)
Generic Name
Trimetazidine Dihydrochloride
Strength
35 mg
Manufacturer
Healthcare Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 8.00 (5 x 10: ৳ 400.00) Strip Price: ৳ 80.00
🔹 Indications
Vestar MR is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
🔹 Pharmacology
Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.
🔹 Dosage & Administration
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.
🔹 Interaction
No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.
🔹 Contraindications
Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.
🔹 Side Effects
Vestar MR is safe and well tolerated. The Common side effects associated with Vestar MR are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia
🔹 Pregnancy & Lactation
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.
🔹 Precautions & Warnings
Vestar MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.
🔹 Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
🔍 People also search for
Vestar MR
Vestar MR Tablet (Modified Release) used for
Vestar MR side effects
Vestar MR price
Vestar MR dose
Vestar MR Tablet (Modified Release) uses
Is Vestar MR safe
Vestar MR dosage
Vestar MR alternative
Vestar MR Bangladesh
Trimetazidine Dihydrochloride
Trimetazidine Dihydrochloride price Bangladesh
Tablet (Modified Release) price Bangladesh
Healthcare Pharmaceuticals Ltd.
medicine bd
Vestar MR 35 mg
Vestar MR 35 mg price
💡 Frequently Asked Questions
Vestar MR is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response....
Vestar MR is safe and well tolerated. The Common side effects associated with Vestar MR are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia
User Reviews
⭐
No reviews yet!
Be the first to share your experience.